REGENXBIO, Inc. (RGNX)
7.65
-0.38
(-4.73%)
USD |
NASDAQ |
Nov 13, 16:00
7.65
0.00 (0.00%)
After-Hours: 19:59
REGENXBIO Price to Book Value : 3.417 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 3.586 |
| November 11, 2026 | 3.783 |
| November 10, 2026 | 3.434 |
| November 09, 2026 | 3.604 |
| November 06, 2026 | 3.403 |
| November 05, 2026 | 3.296 |
| November 04, 2026 | 3.444 |
| November 03, 2026 | 3.408 |
| November 02, 2026 | 3.198 |
| October 30, 2026 | 3.216 |
| October 29, 2026 | 3.310 |
| October 28, 2026 | 3.234 |
| October 27, 2026 | 2.948 |
| October 26, 2026 | 2.939 |
| October 23, 2026 | 2.983 |
| October 22, 2026 | 3.202 |
| October 21, 2026 | 3.202 |
| October 20, 2026 | 3.305 |
| October 19, 2026 | 3.193 |
| October 16, 2026 | 3.093 |
| October 15, 2026 | 3.198 |
| October 14, 2026 | 3.073 |
| October 13, 2026 | 3.242 |
| October 12, 2026 | 3.470 |
| October 09, 2026 | 3.604 |
| Date | Value |
|---|---|
| October 08, 2026 | 3.613 |
| October 07, 2026 | 3.392 |
| October 06, 2026 | 3.327 |
| October 05, 2026 | 3.466 |
| October 02, 2026 | 3.318 |
| October 01, 2026 | 3.314 |
| September 30, 2026 | 3.363 |
| September 29, 2026 | 5.623 |
| September 28, 2026 | 5.638 |
| September 25, 2026 | 5.585 |
| September 24, 2026 | 5.464 |
| September 23, 2026 | 5.661 |
| September 22, 2026 | 6.151 |
| September 21, 2026 | 5.947 |
| September 18, 2026 | 6.061 |
| September 17, 2026 | 6.200 |
| September 16, 2026 | 6.023 |
| September 15, 2026 | 5.996 |
| September 14, 2026 | 6.559 |
| September 11, 2026 | 6.438 |
| September 10, 2026 | 6.461 |
| September 09, 2026 | 6.589 |
| September 08, 2026 | 6.612 |
| September 04, 2026 | 6.747 |
| September 03, 2026 | 6.944 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Anika Therapeutics, Inc. | 1.299 |
| United Therapeutics Corp. | 3.992 |
| Biomea Fusion, Inc. | 5.560 |
| ACADIA Pharmaceuticals, Inc. | 2.334 |
Price to Book Value Related Metrics
| PS Ratio | 2.764 |
| Price | 7.65 |
| Earnings Yield | -41.97% |
| Market Cap | 505.81M |